PMC:7565482 / 3506-3974
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T11 | 113-124 | Body_part | denotes | amino acids | http://purl.org/sig/ont/fma/fma82739 |
T12 | 158-162 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T13 | 418-426 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T20 | 27-35 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T21 | 132-140 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T22 | 290-298 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T23 | 364-372 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T24 | 407-415 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T23 | 47-50 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T24 | 156-162 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
63 | 27-37 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
64 | 132-142 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
65 | 290-300 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
66 | 342-355 | Species | denotes | coronaviruses | Tax:11118 |
67 | 364-372 | Species | denotes | SARS-CoV | Tax:694009 |
68 | 407-417 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T21 | 0-468 | Sentence | denotes | The urgency of the current SARS-CoV-2 pandemic has led researchers to tackle the problem of screening the 10,000 amino acids of the SARS-CoV-2 proteome for T cell responses by selecting viral sequences based on different criteria: (i) bioinformatically predicted epitopes, (ii) homology of SARS-CoV-2 sequences with epitopes defined in other coronaviruses (mainly SARS-CoV) or (iii) selecting some specific SARS-CoV-2 proteins over others [5,7,9,11,14,15,16,17,18,19]. |